KRM Ayurveda Limited is an Ayurveda-based healthcare company operating an integrated network of hospitals, clinics, telemedicine services, and Ayurvedic product offerings. The company has established its presence across multiple cities in India and has also expanded internationally through tele-consultation services and the sale of Ayurvedic medicines.
KRM Ayurveda currently operates 6 hospitals and 5 clinics across various locations in the country. The company initially commenced operations as a specialized kidney care hospital and has since diversified its healthcare services to address a broad range of chronic and lifestyle-related disorders, including kidney ailments, liver cirrhosis, diabetes, fatty liver, arthritis, and other metabolic conditions.
KRM Ayurveda’s hospitals and clinics are equipped with Ayurveda-focused infrastructure, including general and premium beds, dedicated Panchakarma treatment units, herbal pharmacies and medicine preparation facilities, Ayurvedic diet kitchens, consultation chambers for qualified Vaidyas, and in-house yoga and meditation halls, enabling comprehensive in-patient, out-patient, and wellness care delivery.
KRM Ayurveda’s hospitals and clinics provide a wide range of Ayurveda-based healthcare services, including:
- In-patient and out-patient care for chronic and lifestyle disorders.
- Panchakarma therapies focused on detoxification and rejuvenation.
- Specialized clinics for orthopaedic care, skin and hair treatment, women’s wellness, and geriatric care.
- Wellness and preventive healthcare packages such as stress and weight management.
- Diet, lifestyle, yoga, and meditation counselling based on individual body constitution (doshas).
- Dispensing and sale of Ayurvedic medicines through in-house pharmacies.
As on December 31, 2025, KRM Ayurveda employed a total of 443 personnel across its hospitals, clinics, manufacturing, telemedicine, and administrative functions, supporting its operations and growth strategy.
KRM Ayurveda IPO – Details
| IPO Opening Date | 21 January 2026 |
| IPO Closing Date | 23 January 2026 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 57,40,000 Shares Worth ₹77.49 Crore Fresh Issue: 57,40,000 Shares Worth ₹77.49 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹128 – ₹135 per share |
| Market Lot | 1000 Shares |
| Min Order | 1000 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | Skyline Financial Services Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
KRM Ayurveda IPO – Date Schedule
| IPO Open Date | 21 January 2026 |
| IPO Close Date | 23 January 2026 |
| Basis of Allotment | 27 January 2026 |
| Initiation of Refund | 28 January 2026 |
| Credit of Shares to Demat | 28 January 2026 |
| IPO Listing Date | 29 January 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on January 23, 2026 |
KRM Ayurveda IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,70,000 |
| Retail (Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
Competitive Strength
- Skilled Ayurvedic physicians and certified therapists ensuring treatment quality.
- Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy.
- Trusted brand with loyal customer base and repeat clientele.
Company Promoters
- Mr. Puneet Dhawan
- Mrs. Tanya Dhawan
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹89.38 Cr | ₹79.29 Cr | ₹7.60 Cr | ₹19.87 Cr |
| 31 March 2024 | ₹67.57 Cr | ₹62.85 Cr | ₹3.41 Cr | ₹23.18 Cr |
| 31 March 2025 | ₹76.95 Cr | ₹60.61 Cr | ₹12.10 Cr | ₹31.20 Cr |
| 30 September 2025 | ₹48.65 Cr | ₹37.65 Cr | ₹8.14 Cr | ₹25.07 Cr |
Key Performance Indicator
| KPI | Values (Sep 30, 2025) |
|---|---|
| ROE | 21.84% |
| ROCE | 21.84% |
| Debt/Equity | 0.69 |
| RoNW | 21.84% |
| PAT Margin | 16.83 |
| EBITDA Margin | 26.54 |
| Price to Book Value | 5.27 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities. | ₹13.67 |
| Purchase of CRM Software and Hardware Infrastructure. | ₹1.42 |
| Human Resources. | ₹5.44 |
| Repayment/Prepayment of loan. | ₹12.50 |
| Working Capital Requirement. | ₹22.90 |
| General corporate purposes. | – |
✅Strengths
- Integrated hospitals, clinics, telemedicine, and Ayurvedic product model.
- Network of 6 hospitals and 5 clinics.
- Focus on chronic and lifestyle diseases.
- Scalable telemedicine with overseas reach.
- In-house Ayurvedic medicines and supplements.
- Promoter-led and doctor-driven operations.
⚠️Risks
- Dependence on promoters and key doctors.
- Regulatory and compliance risks (AYUSH, Drugs & Cosmetics).
- Operational complexity across locations.
- Dependence on herbal raw material availability.
- Competition from Ayurveda chains and allopathy players.
- Limited brand presence in new regions.
KRM Ayurveda IPO Promoter Holding
| Pre-Issue Share Holding | 92.16% |
| Post Issue Share Holding | 67.28% |
KRM Ayurveda IPO Prospectus
Company Contact Information
| KRM Ayurveda Ltd. A-16 G T Karnal Road, Industrial Area, North West Delhi, New Delhi, 110033 Phone: +91- 9289101700 Email: compliance@krmayurveda.com Website: https://www.krmayurvedaindia.com/ |
KRM Ayurveda IPO Registrar
| Skyline Financial Services Pvt. Ltd. Phone: 02228511022 Email: ipo@skylinerta.com Website: https://www.skylinerta.com/ipo.php |
KRM Ayurveda IPO Lead Manager(s)
| 1. NEXGEN Financial Solutions Pvt. Ltd. |
KRM Ayurveda IPO FAQ
| What is the KRM Ayurveda IPO? KRM Ayurveda IPO is an SME IPO. The issue is priced at ₹128 – ₹135 per equity share. The IPO is to be listed on NSE SME. |
| When will KRM Ayurveda IPO open? The IPO is to open on 21 January 2026 for QIB, NII, and Retail Investors. |
| What is KRM Ayurveda IPO Investors’ Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the KRM Ayurveda IPO Size? KRM Ayurveda IPO size is ₹77.49 Crore. |
| What are the KRM Ayurveda IPO Minimum and Maximum Lot Sizes for Retail Investors? The minimum bid is 2000 Shares for ₹2,70,000, while the maximum bid is 2000 Shares for ₹2,70,000. |
| What is the KRM Ayurveda IPO Allotment Date? KRM Ayurveda IPO allotment date is 27 January 2026. |
| What is the KRM Ayurveda IPO Listing Date? KRM Ayurveda IPO listing date is 29 January 2026. The IPO is to be listed on the NSE SME. |
